Form 4: Schrodinger EVP & CFO Rachit Jain Reports Stock and Option Grants
SEC Form 4
Rachit Jain, EVP & CFO of Schrodinger, Inc., reports the acquisition of restricted stock units and stock options.
Summary
- On May 21, 2025, Rachit Jain, the EVP & CFO of Schrodinger, Inc., was granted 9,375 restricted stock units (RSUs) and an option to purchase 18,750 shares of common stock.
- The RSUs will vest in equal installments on July 15 of 2026, 2027, 2028, and 2029, contingent upon continued service with the company.
- The stock options, with an exercise price of $20.51, vest 25% on May 16, 2025, and the remainder in equal monthly installments through May 16, 2029, also subject to continued service.
- Following these transactions, Jain beneficially owns 37,097 shares of common stock, including 35,530 unvested RSUs, and options to purchase 18,750 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of equity suggests confidence in the company's future performance and aligns executive interests with shareholders.
Positives
- The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to drive long-term value creation.
Industry Context
Stock and option grants are a common practice in the tech and biotech industries to incentivize executives and align their interests with shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are common in the pharmaceutical and software industries.
- Companies like Relay Therapeutics and Recursion Pharmaceuticals also utilize equity-based compensation to attract and retain key personnel.
- The vesting schedules and grant sizes are generally comparable to industry standards for similar roles and company sizes.
Stakeholder Impact
- The grant of equity to the CFO could positively impact shareholders by incentivizing him to improve company performance.
- Employees may view the equity grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | 25% of stock options vest |
| 05/21/2025 | Date of RSU and stock option grant |
| 05/21/2035 | Expiration date of stock options |
| 07/15/2026 | First RSU vesting date |
| 07/15/2027 | Second RSU vesting date |
| 07/15/2028 | Third RSU vesting date |
| 07/15/2029 | Final RSU vesting date |
Keywords
Schrodinger, Rachit Jain, RSU, Stock Option, Beneficial Ownership, Form 4, SDGR, EVP & CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.